MMP9 and breast cancer: Silibinin inhibits phosphorylated extracellular signal-regulated kinases (p-ERK) and phosphorylated mitogen-activated protein kinase (p-MEK), thereby inhibiting MMP-9 expression and BC cell migration [114].